Found: 7
Select item for more details and to access through your institution.
Presence of autoantibodies in serum does not impact the occurrence of immune checkpoint inhibitor-induced hepatitis in a prospective cohort of cancer patients.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 3, p. 647, doi. 10.1007/s00432-021-03870-6
- By:
- Publication type:
- Article
Absolute and relative differential blood count predicts survival of AJCC stage I‐II melanoma patients scheduled for sentinel lymph node biopsy.
- Published in:
- Australasian Journal of Dermatology, 2020, v. 61, n. 3, p. e310, doi. 10.1111/ajd.13248
- By:
- Publication type:
- Article
Swiss Recommendations for Cutaneous Basal Cell Carcinoma.
- Published in:
- Dermatology (10188665), 2023, v. 239, n. 1, p. 122, doi. 10.1159/000526478
- By:
- Publication type:
- Article
Prognostic role of gamma-glutamyl transferase in metastatic melanoma patients treated with immune checkpoint inhibitors.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 4, p. 1089, doi. 10.1007/s00262-020-02768-5
- By:
- Publication type:
- Article
S100B and LDH as early prognostic markers for response and overall survival in melanoma patients treated with anti-PD-1 or combined anti-PD-1 plus anti-CTLA-4 antibodies.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Diminished levels of the soluble form of RAGE are related to poor survival in malignant melanoma.
- Published in:
- International Journal of Cancer, 2015, v. 137, n. 11, p. 2607, doi. 10.1002/ijc.29619
- By:
- Publication type:
- Article
Serum S100B and LDH at Baseline and During Therapy Predict the Outcome of Metastatic Melanoma Patients Treated with BRAF Inhibitors.
- Published in:
- Targeted Oncology, 2021, v. 16, n. 2, p. 197, doi. 10.1007/s11523-021-00792-8
- By:
- Publication type:
- Article